Enterprise value:
$3.61B+$33.65M(+0.94%)Summary
- As of today (September 14, 2025), CRSP enterprise value is $3.61 billion, with a rise of +$33.65 million (+0.94%) during the most recent trading session on September 12, 2025.
- Over the past year, CRSP enterprise value has increased by +$1.47 billion (+68.73%).
- CRSP enterprise value is now -74.04% below its all-time high of $13.90 billion.
Performance
CRSP Enterprise value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CRSP Enterprise value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +0.9% | +0.7% | +0.7% |
| 1 m1 month | -0.8% | -0.6% | -0.6% |
| 3 m3 months | +87.3% | +43.5% | +36.3% |
| 6 m6 months | +76.0% | +37.2% | +29.4% |
| ytdytd | +112.9% | +51.6% | +42.9% |
| 1 y1 year | +68.7% | +30.9% | +22.6% |
| 5 y5 years | -23.5% | -8.8% | -29.7% |
CRSP Enterprise value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $3.92B | -8.0% | $3.20B | +12.6% |
| 3 m | 3-month | $4.51B | -20.1% | $1.93B | +87.3% |
| 6 m | 6-month | $4.51B | -20.1% | $1.06B | +240.0% |
| 1 y | 1-year | $4.51B | -20.1% | $1.06B | +240.0% |
| 3 y | 3-year | $6.05B | -40.4% | $1.06B | +240.0% |
| 5 y | 5-year | $13.90B | -74.0% | $1.06B | +240.0% |
| alltime | all time | $13.90B | -74.0% | $256M | +1309.8% |
CRSP Enterprise value History
| Date | Value |
|---|---|
| 2025 | $3.61B(+112.9%) |
| 2024 | $1.69B(-52.3%) |
| 2023 | $3.56B(+119.5%) |
| 2022 | $1.62B(-56.0%) |
| 2021 | $3.68B(-62.0%) |
| Date | Value |
|---|---|
| 2020 | $9.69B(+244.7%) |
| 2019 | $2.81B(+174.3%) |
| 2018 | $1.02B(+43.7%) |
| 2017 | $713.35M(+45.8%) |
| 2016 | $489.20M |
FAQ
- What is CRISPR Therapeutics AG enterprise value?
- What is the all time high enterprise value for CRISPR Therapeutics AG?
- What is CRSP enterprise value year-to-date change?
- What is CRISPR Therapeutics AG enterprise value year-on-year change?
What is CRISPR Therapeutics AG enterprise value?
The current enterprise value of CRSP is $3.61B
What is the all time high enterprise value for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high enterprise value is $13.90B
What is CRSP enterprise value year-to-date change?
CRISPR Therapeutics AG enterprise value has changed by +$1.91B (+112.88%) since the beginning of the year
What is CRISPR Therapeutics AG enterprise value year-on-year change?
Over the past year, CRSP enterprise value has changed by +$1.47B (+68.73%)